Zobrazeno 21 - 30
of 236
pro vyhledávání: '"Shuichi Miyawaki"'
Autor:
Keisuke Kataoka, Hisashi Tsurumi, Yotaro Ochi, Ryunosuke Saiki, Yusuke Shiozawa, Akinori Yoda, Hideki Makishima, Ken Ishiyama, Akira Hangaishi, Masashi Sanada, Ayana Kon, Seishi Ogawa, Takayuki Ishikawa, Yuichi Shiraishi, Arnold Ganser, Hideyuki Nakazawa, Nobuhiro Hiramoto, Shuichi Miyawaki, Michael Heuser, Kenichi Yoshida, Masahiro Nakagawa, Jaroslaw P. Maciejewski, Yasuhito Nannya, Kenichi Chiba, Toshiyuki Kitano, Lee-Yung Shih, Akifumi Takaori-Kondo, Yasunobu Nagata, Cassandra M Kerr, Yasushi Miyazaki, Hiroko Tanaka, Tetsuichi Yoshizato, Felicitas Thol, June Takeda, Kensuke Usuki, Satoru Miyano
Publikováno v:
Blood. 134:914-914
Acute erythroid leukemia (AEL) is a unique subtype of acute myeloid leukemia (AML) characterized by erythroid predominance and dysplasia, which is morphologically classified into two subtypes: pure erythroid and myeloid/erythroid leukemias (PEL and M
Autor:
Hidemasa, Matsuo, Kenichi, Yoshida, Kazutaka, Fukumura, Kana, Nakatani, Yuki, Noguchi, Saho, Takasaki, Mina, Noura, Yusuke, Shiozawa, Yuichi, Shiraishi, Kenichi, Chiba, Hiroko, Tanaka, Ai, Okada, Yasuhito, Nannya, June, Takeda, Hiroo, Ueno, Norio, Shiba, Genki, Yamato, Hiroshi, Handa, Yuichiro, Ono, Nobuhiro, Hiramoto, Takayuki, Ishikawa, Kensuke, Usuki, Ken, Ishiyama, Shuichi, Miyawaki, Hidehiro, Itonaga, Yasushi, Miyazaki, Machiko, Kawamura, Hiroki, Yamaguchi, Nobutaka, Kiyokawa, Daisuke, Tomizawa, Takashi, Taga, Akio, Tawa, Yasuhide, Hayashi, Hiroyuki, Mano, Satoru, Miyano, Yasuhiko, Kamikubo, Seishi, Ogawa, Souichi, Adachi
Publikováno v:
Blood advances. 2(21)
Novel CCND3 mutations were identified, and CDK4/6 inhibitors represent a promising therapeutic option for MLL-rearranged AML.Coexisting mutations had a negative prognostic impact on pediatric MLL-MLLT3–rearranged AML patients.
Autor:
Kensuke Usuki, Toru Sakura, Masahito Kaneko, Tomoki Naoe, Satoshi Morita, Yukio Kobayashi, Shunsuke Yamada, Toshihiro Miyamoto, Shigeru Takeshita, Hiroatsu Iida, Erkut Bahceci, Mikiko Kusano, Shuichi Miyawaki
Publikováno v:
Cancer Science
Gilteritinib, a novel, highly specific, potent fms-like tyrosine kinase 3/AXL inhibitor, demonstrated antileukemic activity in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML). In this open-label phase 1 study (NCT02181660), Japan
Autor:
Shuichi Miyawaki, Tatsuya Konishi, Hideharu Muto, Junji Tomiyama, Noriko Doki, Ryoko Sakuma, Kazuteru Ohashi
Publikováno v:
International Journal of Hematology. 110:127-128
Autor:
Naoko Hosono, Nobuhiro Hiramoto, Shuichi Miyawaki, Yoshinobu Kanda, Hiroyuki Fujita, Shigeki Ohtake, Hitoshi Kiyoi, Itaru Matsumura, Tomoki Naoe, Minoru Yoshida, Hiroshi Handa, Hitoshi Minamiguchi, Shun-ichi Kimura, Jun-ichi Miyatake, Tsutomu Takahashi, Yasushi Miyazaki, Hideaki Kato, Nobu Akiyama, Kazuyuki Shigeno
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 26(12)
The Japan Adult Leukemia Study Group (JALSG) AML201 protocols are regimens for remission induction and consolidation chemotherapy of acute myeloid leukemia (AML) and have been widely accepted in Japan since 2001. Management of infectious complication
Autor:
Hiroyuki Fujita, Shun-ichi Kimura, Nobuhiro Hiramoto, Shuichi Miyawaki, Yoshinobu Kanda, Itaru Matsumura, Jun-ichi Miyatake, Tsutomu Takahashi, Yasushi Miyazaki, Hideaki Kato, Minoru Yoshida, Nobu Akiyama, Naoko Hosono, Kazuyuki Shigeno, Tomoki Naoe, Shigeki Ohtake, Hiroshi Handa, Hitoshi Minamiguchi, Hitoshi Kiyoi
Publikováno v:
Open Forum Infectious Diseases
Background Remission induction (RI) chemotherapy for acute myeloid leukemia (AML) is one of the most intensive chemotherapy available. Antibiotic prophylaxis and prompt treatment for infectious complications during RI chemotherapy play a major role i
Autor:
Noriko Doki, Shinichiro Okamoto, Shinichi Kako, Takehiko Mori, Shuichi Miyawaki, Takayuki Saitoh, Yoshinobu Kanda, Hiroaki Shimizu, Toru Sakura, Shinichiro Machida, Heiwa Kanamori
Publikováno v:
European Journal of Haematology. 95:455-460
Adult patients with mixed phenotype acute leukemia (MPAL) have a poor prognosis, and the therapeutic role of allogeneic stem cell transplantation (allo-SCT) for MPAL remains to be elucidated. Thus, we retrospectively assessed the efficacy of allo-SCT
Autor:
Akio Tawa, Toru Sakura, Takashi Taga, Shuichi Miyawaki, Nobutaka Kiyokawa, Kunio Kitamura, Takao Deguchi, Hayato Miyachi, Yuka Iijima-Yamashita, Youko Suehiro, Yasunobu Nagata, Yasushi Miyazaki, Daisuke Tomizawa, Yachiyo Kuwatsuka, Heiwa Kanamori, Emiko Sakaida, Katsuyoshi Koh, Hiroaki Goto, Yukiyasu Ozawa, Norio Shiba, Yoshiyuki Kosaka, Kiyotoshi Imai, Noriko Usui, Shigeki Ohtake, Akira Shimada, Yoshikazu Ito, Akiko Saito, Yasuhide Hayashi, Tomoki Naoe, Shuki Mizutani, Atsushi Manabe, Souichi Adachi, Keizo Horibe, Hideki Nakayama, Rika Kihara, Akitoshi Kinoshita, Seishi Ogawa, Shinichi Kobayashi, Norio Asou, Hitoshi Kiyoi
Publikováno v:
International journal of hematology. 107(2)
Clinical outcomes and the genetic background of acute myeloid leukemia (AML) in adolescent and young adults (AYAs) are known to differ in younger children and older adults. To clarify the impact of genetic mutations on clinical outcomes of AYAs with
Autor:
Kinuko Mitani, Sumihisa Honda, Tomoki Naoe, Yoshiaki Ogawa, Masafumi Taniwaki, Noriyoshi Iriyama, Fumihiro Ishida, Hisashi Sakamaki, Tomoya Maeda, Yasushi Miyazaki, Shigeki Ohtake, Masatomo Takahashi, Shuichi Miyawaki, Jin Takeuchi, Yoshihiro Hatta, Tohru Izumi, Toru Sakura, Tomohiko Taki
Publikováno v:
Leukemia Research. 37:1021-1026
We investigated the significance of surface antigen expression for prognosis by focusing on a specific subtype, AML with t(8;21). The investigation included 144 patients with AML with t(8;21) in the JALSG AML97 study. AML with t(8;21) expressed CD19
Autor:
Masaki Yamaguchi, Toru Kiguchi, Ei Leen Liew, Takahiro Yoshida, Naoki Takezako, Shuichi Miyawaki, Tomoki Naoe, Yuji Heike, Kaori Mitsuki
Publikováno v:
Blood. 132:29-29
Introduction: In recent decades, a considerable number of tumor antigens have been characterized, including the leukemia-associated antigen, Wilm's tumor 1 (WT1). WT1 is found to be expressed at low levels in various normal tissues such as gonads, ki